Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

14.97
Delayed Data
As of Apr 21
 -0.03 / -0.20%
Today’s Change
11.52
Today|||52-Week Range
19.62
+8.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues2.2M22.9M130.0M83.3M
 
 
 
 
 
Depreciation And Amortization2.9M1.9M727.0K2.1M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses103.9M101.2M118.3M219.1M
 
 
 
 
 
Research And Development89.7M84.4M95.2M178.2M
 
 
 
 
 
Total Operating Expenses106.8M103.1M119.0M221.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-104.6M-80.2M11.0M-137.9M
 
 
 
 
 
Extraordinary Credit2.2M--0.00703.0K
 
 
 
Extraordinary Charge0.00-20.1M-9.5M--
 
 
 
Interest Expense On Debt2.0M2.3M6.7M6.6M
 
 
 
 
 
Other Expenses59.0K2.3M572.0K2.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-104.1M-100.4M-4.7M-141.4M
 
 
 
 
 
Income Taxes0.00-70.0K0.000.00
 
 
Net Income-104.1M-100.3M-4.7M-141.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS73.3M76.3M103.6M103.9M
 
 
 
 
 
Shares To Calculate EPS Diluted73.3M76.3M103.6M103.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.40-$1.33-$0.05-$1.36
 
 
 
 
 
EPS Diluted-$1.40-$1.33-$0.05-$1.36